ORGAPRED selects CYTOQUBE® from Hamamatsu Photonics for personalized oncology research and therapeutic discovery
ORGAPRED, a France-based core facility specializing in Affected person-Derived Tumor Organoid (PDTO) analysis, has chosen the CYTOQUBE high-throughput 3D imaging ...